$MRNA News and Market Events
Every $MRNA story Market Flux has tracked.
- Most Active
Moderna Shares Whipsaw for Third Session After Phase 3 Cancer Vaccine Surge
Moderna shares have swung violently for three consecutive sessions following positive Phase 3 results for its personalized mRNA cancer vaccine, which triggered a roughly 177% single-session…
- Most Active
Moderna Sheds Up to 25% and 18 Billion in Market Cap as Investors Pocket Gains From Historic Cancer Vaccine Surge
Moderna shares fell as much as 25% on Thursday, erasing roughly 18 billion dollars in market value after closing Wednesday up 176.9% on breakthrough Phase 3 cancer vaccine trial results…
- Unusual Volume
Moderna Sheds Up to 25% in Profit-Taking Selloff After Historic 177% Cancer Vaccine Surge
Moderna shares fell as much as 25% on Thursday, erasing roughly $18 billion in market value after the stock's record single-day gain of 176.9% on Wednesday. The rally had been driven by…
- Most Active
Moderna Surges 177% After mRNA Melanoma Vaccine Succeeds in First-Ever Phase 3 Cancer Vaccine Trial
Moderna shares closed up 177% on Wednesday, their best single day on record, adding roughly $44 billion in market cap after the company and partner Merck announced positive topline results…
- Top Mover
Moderna Surges 177% in Best Day Ever After mRNA Cancer Vaccine Succeeds in Phase 3 Trial
Moderna shares soared 177% on Wednesday, their best single-day gain on record, adding roughly $44 billion in market cap and lifting the stock from a prior close of $62.96 to as high as the…
- Unusual Volume
Moderna Surges Record 177% After Melanoma Vaccine Succeeds in Phase 3 Trial With Merck
Moderna and Merck reported positive topline results Wednesday from the Phase 3 INTerpath-001 trial of intismeran autogene, a personalized mRNA-based individualized neoantigen therapy…